TXMD — TherapeuticsMD, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 25743 ·
Last close
$2.05
Market Cap
$23.73M
52W High
$2.95
52W Low
$0.99
ADV30
30,773
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 724,000 | — | -723,000 | 95,000 | 37,581,000 | 8,419,000 | 10,608,000 |
| Dec 2025 | 893,000 | — | -1,496,000 | -619,000 | 37,656,000 | 7,483,000 | 10,780,000 |
| Sep 2025 | 784,000 | — | -830,000 | 152,000 | 38,671,000 | 7,115,000 | 11,227,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,699,000
Investing CF
—
Financing CF
$0
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.01
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-952,296,000
Inventory
—
Receivables
$3,870,000
ST Investments
—
EBIT TTM
$-4,271,000
Pretax Income TTM
$118,000
Interest Exp TTM
$7,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,270,000
EBITDA
$-1,369,000
Free Cash Flow
$896,625
Enterprise Value
$21,371,622
Total Cash
$9,189,000
Total Debt
$5,560,000
Shares Out
11,574,362
Trailing EPS
$-0.03
Book Value
$2.33
ROE
-1.1%
ROA
-2.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 3,022,000 | -4,214,000 | -569,000 | 37,656,000 | 10,780,000 | 26,876,000 | 2,454,000 |
| Dec 2024 | 1,761,000 | -4,844,000 | -2,181,000 | 38,822,000 | 11,452,000 | 27,370,000 | 1,170,000 |
| Dec 2023 | 1,302,000 | -8,523,000 | -10,278,000 | 43,309,000 | 14,022,000 | 29,287,000 | -23,081,000 |
| Dec 2022 | 69,963,000 | 10,663,000 | 111,997,000 | 90,458,000 | 55,315,000 | 35,143,000 | 9,359,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.35
Max Pain — expiry 2027-03-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.00 · spot: $2.04 · call volume: 211 · put volume: 1Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| UPC | Universe Pharmaceuticals INC | $23.79M | $4.75 | — |
| RADX | Radiopharm Theranostics Ltd | $23.86M | $1.65 | — |
| NXTC | NextCure, Inc. | $23.25M | $5.08 | — |
| PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | $23.12M | $0.05 | — |
| QNTM | Quantum Biopharma Ltd. | $24.75M | $3.85 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.